Related Experiment Video

Updated: Apr 21, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.5K

Common variants associated with general and MMR vaccine-related febrile seizures

Bjarke Feenstra1, Björn Pasternak1, Frank Geller1

  • 1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Nature Genetics
|October 27, 2014
PubMed

Insights

Genetic studies identified key genes linked to febrile seizures after measles, mumps, and rubella (MMR) vaccination. These findings advance our understanding of vaccine safety and epilepsy risk.

Area of Science:

  • Genetics
  • Immunology
  • Neurology

Background:

  • Febrile seizures are a recognized adverse event following measles, mumps, and rubella (MMR) vaccination.
  • Understanding the genetic underpinnings of these seizures is crucial for vaccine safety and epilepsy research.

Purpose of the Study:

  • To identify genetic loci associated with febrile seizures, particularly those linked to MMR vaccination.
  • To investigate the genetic factors contributing to febrile seizures in general.

Main Methods:

  • Genome-wide association scans (GWAS) were performed comparing children with MMR-related febrile seizures, MMR-unrelated febrile seizures, and controls.
  • Statistical analyses identified significant genetic associations with specific loci.

Main Results:

  • Two loci were significantly associated with MMR-related febrile seizures, including genes related to interferon stimulation (IFI44L) and measles virus entry (CD46).
  • Four loci were associated with febrile seizures generally, implicating sodium channel genes (SCN1A, SCN2A), ANO3, and a region linked to magnesium levels.
  • Functional studies confirmed the role of ANO3 (TMEM16C) in seizure mechanisms using rat models.

Conclusions:

  • Genetic variations in IFI44L and CD46 may predispose individuals to febrile seizures post-MMR vaccination.
  • SCN1A, SCN2A, ANO3, and 12q21.33 represent important genetic factors in febrile seizures.
  • ANO3 plays a functional role in seizure pathophysiology, offering potential therapeutic targets.

More Related Videos

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

6.6K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
5
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.4K
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
178
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
132
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
152